Post‐neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage‐ and regression‐grade independent prognostic information in intestinal‐type gastric adenocarcinoma

Tumour budding (TB) has been associated with adverse clinicopathological factors and poor survival in a plethora of therapy‐naïve carcinoma entities including gastric adenocarcinoma (GC). As conventional histopathological grading is usually omitted in the post‐neoadjuvant setting of GC, our study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Jesinghaus, Moritz, Herz, Anna‐Lina, Kohlruss, Meike, Silva, Miguel, Grass, Albert, Lange, Sebastian, Novotny, Alexander, Ott, Katja, Schmidt, Thomas, Gaida, Matthias, Hapfelmeier, Alexander, Denkert, Carsten, Weichert, Wilko, Keller, Gisela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353660/
https://www.ncbi.nlm.nih.gov/pubmed/35715937
http://dx.doi.org/10.1002/cjp2.284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353660/
https://www.ncbi.nlm.nih.gov/pubmed/35715937
http://dx.doi.org/10.1002/cjp2.284

Ejemplares similares